Home > Publications > Medical Specialty > Internal Medicine > Haematology > CAR-T cell therapy > CAR T-Cell Therapy Research Review, Issue 7
CAR T-Cell Therapy Research Review, Issue 7

CAR T-Cell Therapy Research Review, Issue 7

In this issue:

AEs in CAR-T cell therapy
A novel CD19-1XX CAR with calibrated signalling in LBCL
Anti-BCMA CAR-T cell therapy in R/R AL amyloidosis
Real-world ide-cel in R/R multiple myeloma
Immunological sequelae of CAR-T therapy in R/R DLBCL & multiple myeloma
COVID-19 infection in R/R LBCL undergoing CAR-T cell therapy
ICANS risk not altered by baseline cognitive status or prior neurological injury
Brexu-cel in R/R ALL with CNS involvement
Front-line dasatinib + CAR-T cell therapy in newly diagnosed Ph-positive ALL
The clock drawing task to identify ICANS

You need to be logged in to access this content.

Chanukya-Colonne

Expert contributor

Dr Chanukya Colonne

Chan is a physician-scientist based in Sydney, specialising in CAR-T cell therapy and immuno-oncology, with a focus on advancing treatments for acute myeloid leukaemia (AML). She completed her specialist haematology training at Westmead and Royal Prince Alfred Hospitals, where she gained hands-on experience in the clinical implementation and delivery of CAR-T therapies. Currently, Chan is […]

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.

It looks like you are closest to our New Zealand site.

Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.